Rearden Internal Medicine is categorized under Health Services in North Charleston, SC and active since 2010.
Rearden Internal Medicine was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact G Rearden, Manager at the company’s single location by writing to 3255 Landmark Drive # 102, North Charleston, South Carolina SC 29418 or by phoning (843) 760-0069. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rearden Internal Medicine |
| Contact Person: | G Rearden, Manager |
| Address: | 3255 Landmark Drive # 102, North Charleston, South Carolina 29418 |
| Phone Number: | (843) 760-0069 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6214930 |
| Share This Business: |
Rearden Internal Medicine was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact G Rearden, Manager for inquiries that concern Rearden Internal Medicine by calling the company number (843) 760-0069, as your correspondence is most welcome. Additionally, the physical location of the single location of Rearden Internal Medicine can be found at the coordinates 32.92939,-80.06998 as well as the street address 3255 Landmark Drive # 102 in North Charleston, South Carolina 29418.
For its online presence, you may visit Rearden Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.